Novacyt S.A. (EPA:ALNOV)
France · Delayed Price · Currency is EUR 0.4020
+0.0015 (0.37%)
Jan 9, 2026, 5:35 PM CET
Novacyt Market Cap
Novacyt has a market cap or net worth of €28.35 million as of January 9, 2026. Its market cap has decreased by -33.26% in one year.
Market Cap
28.35M
Enterprise Value
13.45M
Revenue
22.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.40
Market Cap Chart
Since October 12, 2012, Novacyt's market cap has increased from 23.55M to 28.35M, an increase of 20.34%. That is a compound annual growth rate of 1.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 28.35M | 2.81% |
| Dec 31, 2025 | 27.57M | -35.08% |
| Dec 31, 2024 | 42.47M | -15.60% |
| Dec 29, 2023 | 50.32M | -42.02% |
| Dec 30, 2022 | 86.78M | -71.94% |
| Dec 31, 2021 | 309.30M | -55.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 127.83B |
| Sanofi | 100.13B |
| Sartorius Stedim Biotech | 21.50B |
| bioMérieux | 13.55B |
| Eurofins Scientific SE | 12.17B |
| Ipsen | 9.93B |
| ABIVAX Société Anonyme | 8.05B |
| Virbac | 2.98B |